Secondary hyperparathyroidism is a complex endocrine condition characterized by excess circulating parathyroid hormone (PTH) resulting from an underlying condition, most commonly chronic kidney ...

There’s no cure for hypoparathyroidism, but treatment options like calcium supplements, diuretics, and parathyroid hormone therapy can help regulate your calcium and phosphate levels.

Study suggests the lowest dose of vitamin D3 supplements needed to suppress parathyroid hormone in overweight and obese adults is 1000 IU daily. For overweight and obese individuals, taking 1000 IU of ...

ORLANDO, Fla. — After 2 years of treatment with the parathyroid hormone (PTH) analog palopegteriparatide (Yorvipath), adults with chronic hypoparathyroidism demonstrated continued improvement in renal ...

People can use methods such as dietary changes, supplements, diuretics, and hormone replacement to manage low parathyroid hormone levels. Hypoparathyroidism is a rare condition in which the ...

The US Food and Drug Administration (FDA) has approved palopegteriparatide (Yorvipath) for the treatment of hypoparathyroidism in adults, the drug's manufacturer Ascendis Pharma announced. In ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Palopegteriparatide improved skeletal dynamics and renal ...

The information provided in response to the FDA’s Complete Response Letter "constituted a major amendment to the NDA" requiring more time for review. The Food and Drug Administration (FDA) has ...